Six months chronic toxicological evaluation of naringin in Sprague-Dawley rats

Food and Chemical Toxicology

Volumn 66, Issue , 2014, Pages 65-75

  Li, Peibo ^a   Wang, Sheng ^a   Guan, Xiaolin ^b   Cen, Xiaobo ^b   Hu, Chunyan ^b   Peng, Wei ^a   Wang, Yonggang ^a   Su, Weiwei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b National Chengdu Center for Safety Evaluation of Drugs   (China)

Author keywords

Chronic toxicological evaluation; Naringin; Six months; Sprague Dawley rats

Indexed keywords

AURANTIIN; ESTRADIOL; TESTOSTERONE; FLAVANONE DERIVATIVE; SEX HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; BODY WEIGHT; ESTRADIOL BLOOD LEVEL; FEMALE; FOOD ANALYSIS; FOOD INTAKE; FOOD POISONING; FOOD SAFETY; HAIR LOSS; HISTOPATHOLOGY; LONG TERM EXPOSURE; MALE; NONHUMAN; ORGAN WEIGHT; PUMMELO; TESTOSTERONE BLOOD LEVEL; TOXICITY TESTING; ANIMAL; BLOOD; DOSE RESPONSE; DRUG EFFECTS; FEEDING BEHAVIOR; ORAL DRUG ADMINISTRATION; ORGAN SIZE; RAT; SPRAGUE DAWLEY RAT; TOXICITY;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEEDING BEHAVIOR; FEMALE; FLAVANONES; GONADAL STEROID HORMONES; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; TOXICITY TESTS, CHRONIC;

EID: 84896727670     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.01.023     Document Type: Article

References (55)

1. Alam M.A., Kauter K., Brown L. Naringinimproves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats. Nutrients 2013, 5(3):637-650.
2. Ang E.S., Yang X., Chen H., Liu Q., Zheng M.H., Xu J. Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-kappaB and ERK activation. FEBS Lett. 2011, 585:2755-2762.
3. - mice. J. Lipid Res. 2013, 54(3):711-724.
4. Camargo C.A., Gomes-Marcondes M.C., Wutzki N.C., Aoyama H. Naringin inhibits tumor growth and reduces interleukin-6 and tumor necrosis factor alpha levels in rats with Walker 256 carcinosarcoma. Anticancer Res. 2012, 32:129-133.
5. Chen Y., Nie Y.C., Luo Y.L., Lin F., Zheng Y.F., Cheng G.H., Wu H., Zhang K.J., Su W.W., Shen J.G., Li P.B. Protective effects of naringin against paraquat-induced acute lung injury and pulmonary fibrosis in mice. Food Chem. Toxicol. 2013, 58C:133-140.
6. Dallas C., Gerbi A., Tenca G., Juchaux F., Bernard F.X. Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of cAMP-phosphodiesterase (PDE). Phytomedicine 2008, 15(10):783-792.
7. Dong Y.S., Yin J.Y., Chen Z., Qu W.S., Yuan B.L., Gao X.X., Ding R.G., Wang H.M. Establishment and application of the normal reference values of organ masses and organ/body coefficients in SD rats. Mil. Med. Sci. 2012, 36(5):351-353.
8. Du G.J., Jin L.T., Han X.F., Song Z.H., Zhang H.Y., Liang W. Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasis. Cancer Res. 2009, 69:3205-3212.
9. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) Scientific opinion on the safety and efficacy of naringin when used as a sensory additive for all animal species. EFSA J. 2011, 9(11):2416.
10. Finner A.M. Nutrition and hair: deficiencies and supplements. Dermatol. Clin. 2013, 31(1):167-172.
11. Galluzzo P., Ascenzi P., Bulzomi P., Marino M. The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation. Endocrinology 2008, 149(5):2567-2575.
12. Gao S., Li P.B., Yang H.L., Fang S.Q., Su W.W. Antitussive effect of naringin on experimentally induced cough in Guinea pigs. Planta Med. 2011, 77:16-21.
13. Gopinath K., Sudhandiran G. Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neuroscience 2012, 227:134-143.
14. Gopinath K., Prakash D., Sudhandiran G. Neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis. Neurochem. Int. 2011, 59:1066-1073.
15. Guo D.Y., Wang J.Z., Wang X.Q., Luo H.J., Zhang H.Q., Cao D., Chen L., Huang N.Y. Double directional adjusting estrogenic effect of naringin from Rhizoma drynariae (Gusuibu). J. Ethnopharmacol. 2011, 138:451-457.
16. Ha H., Lee J.K., Lee H.Y., Seo C.S., Kim J.H., Lee M.Y., Koh W.S., Shin H.K. Evaluation of safety of herbal formula Ojeok-san: acute and subchronic toxicity studies in rats. J. Ethnopharmacol. 2010, 131:410-416.
17. Han Z.Z., Xu H.D., Kim K.H., Ahn T.H., Bae J.S., Lee J.Y., Gil K.H., Lee J.Y., Woo S.J., Yoo H.J., Lee H.K., Kim K.H., Park C.K., Zhang H.S., Song S.W. Reference data of the main physiological parameters in control Sprague-Dawley rats from pre-clinical toxicity studies. Lab Anim. Res. 2010, 26(2):153-164.
18. Jagetia G.C., Reddy T.K. Modulation of radiation-induced alteration in the antioxidant status of mice by naringin. Life Sci. 2005, 77:780-794.
19. Jagetia G.C., Venkatesha V.A., Reddy T.K. Naringin, a citrus flavonone, protects against radiation-induced chromosome damage in mouse bone marrow. Mutagenesis 2003, 18:337-343.
20. Jang Y., Kim T.K., Shim W.S. Naringinexhibits in vivo prokinetic activity via activation of ghrelin receptor in gastrointestinal motility dysfunction rats. Pharmacology 2013, 92(3-4):191-197.
21. Jeon S.M., Kim H.K., Kim H.J., Do G.M., Jeong T.S., Park Y.B., Choi M.S. Hypocholesterolemic and antioxidative effects of naringenin and its two metabolites in high-cholesterol fed rats. Transl. Res. 2007, 149:15-21.
22. Jung U.J., Lee M.K., Park Y.B., Kang M.A., Choi M.S. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int. J. Biochem. Cell Biol. 2006, 38:1134-1145.
23. Kandhare A.D., Raygude K.S., Ghosh P., Ghule A.E., Bodhankar S.L. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia 2012, 83:650-659.
24. Kim D.H., Jung E.A., Sohng I.S., Han J.A., Kim T.H., Han M.J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch. Pharm. Res. 1998, 21:17-23.
25. Kim S.Y., Kim H.J., Lee M.K., Jeon S.M., Do G.M., Kwon E.Y., Cho Y.Y., Kim D.J., Jeong K.S., Park Y.B., Ha T.Y., Choi M.S. Naringin time-dependently lowers hepatic cholesterol biosynthesis and plasma cholesterol in rats fed high fat and high-cholesterol diet. J. Med. Food 2006, 9:582-586.
26. Lauro M.R., De Simone F., Sansone F., Iannelli P., Aquino R.P. Preparations and release characteristics of naringin and naringenin gastro-resistant microparticles by spraydrying. J. Drug Del. Sci. Technol. 2007, 17:119-124.
27. Li H.Z., Yang B., Huang J., Xiang T.X., Yin X.D., Wan J.Y., Luo F.L., Zhang L., Li H.Y., Ren G.S. Naringininhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway. Toxicol. Lett. 2013, 220(3):219-228.
28. Li N.H., Jiang Y.P., Wooley P.H., Xu Z.W., Yang S.Y. Naringin promotes osteoblast differentiation and effectively reverses ovariectomy-associated osteoporosis. J. Orthop. Sci. 2013, 18(3):478-485.
29. Li P.B., Wang S., Guan X.L., Liu B., Wang Y.G., Xu K., Peng W., Su W.W., Zhang K.J. Acute and 13 weeks subchronic toxicological evaluation of naringin in Sprague-Dawley rats. Food Chem. Toxicol. 2013, 60:1-9.
30. Luo Y.L., Zhang C.C., Li P.B., Nie Y.C., Wu H., Shen J.G., Su W.W. Naringin attenuates enhanced cough, airway hyperresponsiveness and airway inflammation in a guinea pig model of chronic bronchitis induced by cigarette smoke. Int. Immunopharmacol. 2012, 13:301-307.
31. Maratha S.R., Mahadevan N. Memory enhancing activity of naringin in unstressed and stressed mice. Possible cholinergic and nitriergic modulation. Neurochem. Res. 2012, 37:2206-2212.
32. Mulvihill E.E., Allister E.M., Sutherland B.G., Telford D.E., Sawyez C.G., Edwards J.Y., Markle J.M., Hegele R.A., Huff M.W. Naringenin prevents dyslipidemia, apolipoproteinBoverproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes 2009, 58(10):2198-2210.
33. Muthaiah V.P., Venkitasamy L., Michael F.M., Chandrasekar K., Venkatachalam S. Neuroprotective role ofnaringeninon carbaryl induced neurotoxicity in mouse neuroblastoma cells. J. Pharmacol. Pharmacother. 2013, 4(3):192-197.
34. Nie Y.C., Wu H., Li P.B., Luo Y.L., Long K., Xie L.M., Shen J.G., Su W.W. Anti-inflammatory effects of naringin in chronic pulmonary neutrophilic inflammation in cigarette smoke-exposed rats. J. Med. Food 2012, 15:894-900.
35. Nishimura Fde.C., de Almeida A.C., Ratti B.A., Ueda-Nakamura T., Nakamura C.V., Ximenes V.F., Silva Sde.O. Antioxidant effects of quercetin andnaringeninare associated with impaired neutrophil microbicidal activity. Evid. Based Complement Alternat. Med. 2013, 2013:795916.
36. Pang W.Y., Wang X.L., Mok S.K., Lai W.P., Chow H.K., Leung P.C., Yao X.S., Wong M.S. Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells. Br. J. Pharmacol. 2010, 159:1693-1703.
37. Parmar H.S., Jain P., Chauhan D.S., Bhinchar M.K., Munjal V., Yusuf M., Choube K., Tawani A., Tiwari V., Manivannan E., Kumar A. DPP-IV inhibitory potential of naringin: an in silico, in vitro and in vivo study. Diabetes Res. Clin. Pract. 2012, 97:105-111.
38. Petterino C., Argentino-Storino A. Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies. Exp. Toxicol. Pathol. 2006, 57:213-219.
39. Prakash A., Shur B., Kumar A. Naringinprotects memory impairment and mitochondrial oxidative damage against aluminum-induced neurotoxicity in rats. Int. J. Neurosci. 2013, 123(9):636-645.
40. Pu P., Gao D.M., Mohamed S., Chen J., Zhang J., Zhou X.Y., Zhou N.J., Xie J., Jiang H. Naringin ameliorates metabolic syndrome by activating AMP activated protein kinase in mice fed a high-fat diet. Arch. Biochem. Biophys. 2012, 518:61-70.
41. Punithavathi V.R., Anuthama R., Prince P.S. Combined treatment with naringin and vitamin C ameliorates streptozotocin-induced diabetes in male Wistar rats. J. Appl. Toxicol. 2008, 28:806-813.
42. Qin L., Jin L.T., Lu L.L., Lu X.Y., Zhang C.L., Zhang F.Y., Liang W. Naringenin reduces lung metastasis in a breast cancer resection model. Protein Cell 2011, 2:507-516.
43. Rajadurai M., Prince P.S. Naringin ameliorates mitochondrial lipid peroxides, antioxidants and lipids in isoproterenol-induced myocardial infarction in Wistar rats. Phytother. Res. 2009, 23:358-362.
44. Raza S.S., Khan M.M., Ahmad A., Ashafaq M., Islam F., Wagner A.P., Safhi M.M., Islam F. Neuroprotective effect of naringenin is mediated through suppression of NF-κB signaling pathway in experimental stroke. Neuroscience 2013, 230:157-171.
45. Richard A.J., Amini-Vaughan Z., Ribnicky D.M., Stephens J.M. Naringenininhibits adipogenesis and reduces insulin sensitivity and adiponectin expression in adipocytes. Evid. Based Complement Alternat. Med. 2013, 2013:549750.
46. Ruh M.F., Zacharewski T., Connor K., Howell J., Chen I., Safe S. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem. Pharmacol. 1995, 50:1485-1493.
47. Center for Drug Evaluation of State Food and Drug Administration of People's Republic of China, 2005. Technical guidelines of chronic toxicity for traditional Chinese medicine and natural drugs. SFDA guidelines No. [Z] GPT3-1.
48. Sharma A.K., Bharti S., Ojha S., Bhatia J., Kumar N., Ray R., Kumari S., Arya D.S. Up-regulation of PPARgamma, heat shock protein-27 and -72 by naringin attenuates insulin resistance, beta-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br. J. Nutr. 2011, 106:1713-1723.
49. Shin Y.W., Bok S.H., Jeong T.S., Bae K.H., Jeoung N.H., Choi M.S., Lee S.H., Park Y.B. Hypocholesterolemic effect of naringin associated with hepatic cholesterol regulating enzyme changes in rats. Int. J. Vitam. Nutr. Res. 1999, 69:341-347.
50. Tsai S.J., Huang C.S., Mong M.C., Kam W.Y., Huang H.Y., Yin M.C. Anti-inflammatory and antifibrotic effects of naringenin in diabetic mice. J. Agric. Food Chem. 2012, 60:514-521.
51. Wang D.M., Yang Y.J., Zhang L., Zhang X., Guan F.F., Zhang L.F. Naringin enhances CaMKII activity and improves long-term memory in a mouse model of Alzheimer's disease. Int. J. Mol. Sci. 2013, 14:5576-5586.
52. Wei M., Yang Z.L., Li P., Zhang Y.B., Sse W.C. Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model. Am. J. Chin. Med. 2007, 35:663-667.
53. Yi L.T., Liu B.B., Li J., Luo L., Liu Q., Geng D., Tang Y., Xia Y., Wu D. BDNF signaling is necessary for the antidepressant-like effect of naringenin. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 48C:135-141.
54. Yilma A.N., Singh S.R., Morici L., Dennis V.A. Flavonoidnaringenin: a potential immunomodulator for Chlamydia trachomatis inflammation. Mediators Inflamm. 2013, 2013:102457.
55. Zierau O., Gester S., Schwab P., Metz P., Kolba S., Wulf M., Vollmer G. Estrogenic activity of the phytoestrogens naringenin, 6-(1, 1-dimethylallyl) naringenin and 8-prenylnaringenin. Planta Med. 2002, 68:449-451.